Reliability and validity of the Turkish version of the Berg Balance Scale.
Fusun Sahin, Figen Yilmaz, Asli Ozmaden...
https://pubmed.ncbi.nlm.nih.gov/18489806/Actively Recruiting
Led by Bengu Turemenogullari · Updated on 2025-04-09
66
Participants Needed
1
Research Sites
17 weeks
Total Duration
Researchers are investigating the effectiveness and long-term benefits of radiofrequency ablation RFA therapy targeting different numbers of nerves to treat chronic knee pain caused by osteoarthritis. This condition, which results from joint cartilage damage with age, leads to pain, loss of balance, and increased fall risk due to impaired knee proprioception. The study aims to compare RFA applied to 5 nerves, 3 nerves, or 2 nerves to understand which protocol best improves pain, balance, proprioception, and symptoms in knee osteoarthritis. Participants will undergo a diagnostic genicular nerve block to confirm suitability before receiving RFA treatment under ultrasound guidance. Patients are randomly assigned to one of three groups receiving a single RFA session targeting either 2 nerves superior medial and inferior medial, 3 nerves superior medial, superior lateral, and inferior medial, or 5 nerves including the previous three plus recurrent fibular nerve and infrapatellar branch of the saphenous nerve. The procedure uses precise ultrasound and electrical stimulation to locate nerves and applies pulsed radiofrequency at 42C for 120 seconds per nerve, followed by an injection of betamethasone and lidocaine to reduce discomfort. Participants will be evaluated at baseline, 1 month, and 3 months after treatment. Assessments include muscle strength tests of the quadriceps and hamstrings, knee joint proprioception measurements, balance and coordination tests such as Romberg and Single Leg Tests, walking ability, fall risk scales, and quality of life questionnaires. Patients will continue their usual medication and exercise but avoid other knee pain treatments for 3 months. The study monitors safety and effectiveness through these measures over the course of the trial.
CONDITIONS
Efficacy of Ultrasound-Guided Genicular Nerve Radiofrequency Ablation Therapy
B
Bengu Turemenogullari
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Bengu Turemenogullari
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants receive a diagnostic genicular nerve block to assess pain reduction before the main treatment.
1 visit (in-person)
Duration - 1 day
Participants receive a single session of radiofrequency ablation therapy targeting either 2, 3, or 5 genicular nerves to reduce knee pain and improve function.
1 visit (in-person)
Duration - 3 months
Participants are monitored for treatment effects on pain, balance, proprioception, and physical performance over 3 months.
Visits at baseline, 1 month, and 3 months post-treatment
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Fusun Sahin, Figen Yilmaz, Asli Ozmaden...
https://pubmed.ncbi.nlm.nih.gov/18489806/Alison H Chang, Song Joo Lee, Heng Zhao...
https://pubmed.ncbi.nlm.nih.gov/24321442/K O Berg, S L Wood-Dauphinee, J I Williams...
https://pubmed.ncbi.nlm.nih.gov/1468055/Damla Cankurtaran, Ozgur Zeliha Karaahmet, Sadik Yigit Yildiz...
https://pubmed.ncbi.nlm.nih.gov/32606270/Lucy Yardley, Nina Beyer, Klaus Hauer...
https://pubmed.ncbi.nlm.nih.gov/16267188/Morten G Thomsen, Roshan Latifi, Thomas Kallemose...
https://pubmed.ncbi.nlm.nih.gov/27036995/Woo-Jong Choi, Seung-Jun Hwang, Jun-Gol Song...
https://pubmed.ncbi.nlm.nih.gov/21055873/Aaron Conger, Jeremy Gililland, Lucas Anderson...
https://pubmed.ncbi.nlm.nih.gov/34308957/Selin Guven Kose, Zeynep Kirac Unal, Halil Cihan Kose...
https://pubmed.ncbi.nlm.nih.gov/36869680/Yasemin Ulus, Dilek Durmus, Yesim Akyol...
https://pubmed.ncbi.nlm.nih.gov/21831462/Bengu Turemenogullari
Lead Sponsor